Valuation: Monogram Technologies Inc.

Market Cap 244M 217M 202M 184M 348M 23.44B 351M 2.45B 948M 11.98B 915M 895M 38.45B P/E 2023
-5.61x
P/E 2024 -4.73x
Enterprise Value 228M 203M 189M 173M 326M 21.96B 329M 2.29B 888M 11.23B 858M 839M 36.03B EV / Sales 2023
257,522,925x
EV / Sales 2024 -
Free-Float
64.74%
Yield 2023 *
-
Yield 2024 -

Last Transcript: Monogram Technologies Inc.

1 year 5.87
Extreme 5.87
6.42
3 years 1.53
Extreme 1.53
6.42
5 years 1.53
Extreme 1.53
48.99
10 years 1.53
Extreme 1.53
48.99
Date Insider Type Main position Quantity % Market Cap. Importance
10/7/25 Issuer sale

Chief Financial Officer

411,385 1.0125%
10/7/25 Issuer sale

Chief Executive Officer

5,566,330 13.6993%
10/7/25 Issuer sale

Director

40,000 0.0984%
Change 5-day change 1-year change 3-year change Capi.($)
-1.80%-.--%+1.18%+130.77% 244M
+0.84%-3.74%-26.69%+1.85% 167B
-0.07%-2.55%-9.53%+11.07% 111B
+0.90%+1.13%-24.83%+0.58% 105B
-1.24%-0.76%-49.04%-12.75% 74.82B
-0.24%+0.69%+0.16%+72.58% 59.11B
-0.86%+2.96%+13.57%+59.50% 51.8B
-0.71%-3.82%-7.72%-31.41% 48.5B
+0.12%-0.17%-18.21%+20.29% 40.79B
-1.01%-1.45%+28.48%-9.72% 32.54B
Average -0.41%-0.53%-9.26%+24.28% 69.04B
Weighted average by Cap. +0.02%-1.11%-16.32%+10.19%

Financials

2023 2024
Net sales 0.36 0.32 0.3 0.28 0.52 35.09 0.53 3.66 1.42 17.94 1.37 1.34 57.57 -
Net income -13.75M -12.21M -11.4M -10.39M -19.59M -1.32B -19.78M -138M -53.45M -676M -51.61M -50.49M -2.17B -16.33M -14.51M -13.54M -12.34M -23.28M -1.57B -23.49M -164M -63.5M -802M -61.3M -59.97M -2.58B
Net Debt -13.1M -11.64M -10.86M -9.9M -18.67M -1.26B -18.84M -131M -50.93M -644M -49.17M -48.11M -2.07B -15.33M -13.62M -12.71M -11.58M -21.85M -1.47B -22.05M -154M -59.6M -753M -57.54M -56.29M -2.42B
Logo Monogram Technologies Inc.
Monogram Technologies Inc. is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The Company's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. It is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time.
Employees
-
  1. Stock Market
  2. Stocks
  3. MGRM Stock